Gold nanoparticles linked to single-stranded DNA create a simple but versatile genetic testing kit

Tests for identifying genetic variations among individuals, which can be used to develop precisely targeted drug therapies, are a current focus in the emerging field of pharmacogenomics. A*STAR researchers have now developed and patented a customized and elegant nanoprobe for assessing sensitivity to the drug warfarin.

Read the whole article on Physorg

More from Physorg